Company intelligence / Profile preview

illumifin

Ownership: Private
Employees: ~2500
Development stage: Commercial

Overview

illumifin is an active US-based insurance technology company providing third-party administration and tech-enabled business processing services to insurers. It focuses on life, health, long-term care, and annuity markets across individual and group segments. The firm delivers proprietary software solutions for policy management and claims processing. In 2022 it acquired LTCG to expand its capabilities in long-term care claims management.

Industry: Biomedical IT and Biomedical Data Platforms

Beyond the preview

Go deeper on illumifin.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on illumifin.

Explore the full profile